Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions.
about
High-throughput biophysical analysis and data visualization of conformational stability of an IgG1 monoclonal antibody after deglycosylation.Identification of Protein-Excipient Interaction Hotspots Using Computational Approaches.Accelerated formulation development of monoclonal antibodies (mAbs) and mAb-based modalities: review of methods and tools.Liquid formulations for long-term storage of monoclonal IgGs.Cell culture media impact on drug product solution stability.Characterizing monoclonal antibody formulations in arginine glutamate solutions using (1)H NMR spectroscopy.Radar chart array analysis to visualize effects of formulation variables on IgG1 particle formation as measured by multiple analytical techniques.Liquid formulations for stabilizing IgMs during physical stress and long-term storage.Stabilization studies on bacterially produced human paraoxonase 1 for improving its shelf life.
P2860
Q30675226-B379E68E-AAFD-4A85-BA36-AEC8EA78469BQ37050590-938A52EF-00EC-4839-BA7F-91F0CAC66E62Q38313350-6C0A0234-6CC2-4C29-9C3B-69F1494C7B74Q38318567-D3FA16E9-64E5-4B83-8318-527DCEB599D8Q38775603-0D068E7F-BCF8-4A42-910E-2F633D528916Q39428136-5DAD9EFE-E695-4E5E-A7A0-BD0EA5EC3F9CQ40143552-E13F6EF6-83E2-41EA-A2BF-9B921EED4926Q44480024-B3C83B52-3617-4760-8F26-84051DF9CE2CQ54294286-FAFD5FEC-8582-4815-B743-7D0EB31C680B
P2860
Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Formulation design and high-th ...... monoclonal antibody solutions.
@ast
Formulation design and high-th ...... monoclonal antibody solutions.
@en
Formulation design and high-th ...... monoclonal antibody solutions.
@nl
type
label
Formulation design and high-th ...... monoclonal antibody solutions.
@ast
Formulation design and high-th ...... monoclonal antibody solutions.
@en
Formulation design and high-th ...... monoclonal antibody solutions.
@nl
prefLabel
Formulation design and high-th ...... monoclonal antibody solutions.
@ast
Formulation design and high-th ...... monoclonal antibody solutions.
@en
Formulation design and high-th ...... monoclonal antibody solutions.
@nl
P2093
P356
P1476
Formulation design and high-th ...... monoclonal antibody solutions.
@en
P2093
Akhilesh Bhambhani
C Russell Middaugh
David B Volkin
Julian M Kissmann
Ramesh S Kashi
Sangeeta B Joshi
P304
P356
10.1002/JPS.23008
P407
P577
2011-12-06T00:00:00Z